MADISON WHITEHAIR: Open Payments
NPI 1922675818 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 22 payments from 11 companies in 2025. Trend: 2023 $701 · 2024 $1,046 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $300 |
| AstraZeneca Pharmaceuticals LP | 5 | $114 |
| ABIOMED | 2 | $75 |
| PFIZER INC. | 3 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| CVRx, Inc. | 1 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Impulse Dynamics (USA) Inc. | 1 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: Rapiblyk, ONPATTRO, JARDIANCE, Barostim Neo System, WAINUA, VYNDAQEL, FARXIGA, CAMZYOS.
Industry payments across TX — which companies pay providers there.
